The Team

The management and directors of Golden Pine Ventures have a history of past successful ventures in the biotechnology field.  In total, they have successfully launched over two dozen companies, raised over a billion dollars in financing, and have taken several companies public.


Christopher Meldrum

Christopher S. Meldrum – Managing Director

Mr. Meldrum launched Golden Pine Ventures with his father, Peter Meldrum, in 2004. Golden Pine has founded 7 start-up biotechnology and biomedical ventures from major universities in the Southeast and Mid-Atlantic United States.  

Before coming to Golden Pine Ventures Mr. Meldrum held the position of Director, Corporate Alliances, at Paradigm Genetics, a publicly-traded biotechnology company where he led business development efforts for both the healthcare and agriculture businesses.  He held business development positions of increasing responsibility since joining the company in the summer of 2000.  During his time at Paradigm he negotiated 7 revenue-generating collaborations with deal values totaling over $30 million. 

Before joining Paradigm Mr. Meldrum worked as Licensing Associate for Purdue University where he managed the out-licensing of Purdue’s biotechnology and life sciences portfolio.  Prior to his time at Purdue he worked for two years in the University of Minnesota’s technology transfer office.  Over the course of his career he has successfully led negotiations for well over 100 fully-executed deals.

Mr. Meldrum received his MBA from the Carlson School of Management at the University of Minnesota, and his B.A. in Chemistry from the University of Utah.


John Hamer

John E. Hamer, Ph.D. - Director

Dr. Hamer is Managing Partner at DCVC Bio. Prior to joining DCVC, he was a VP at Monsanto and Managing Director of Monsanto Growth Ventures (MGV). Before joining MGV, he was a Managing Director at Burrill & Company.  

Prior to his career in venture capital, Dr. Hamer was an entrepreneur, initially at Paradigm Genetics, where he joined as a visiting scientist before becoming Chief Science Officer and eventually President and CEO following the company’s IPO. After Paradigm, he founded and served as CEO of Arête Therapeutics, which earned backing from leading life science venture firms. Dr. Hamer’s career spans more than three decades of research, senior management and investment experience in the life sciences. 

Dr. Hamer started his career in academia, rising to the rank of Full Professor in the Department of Biological Sciences at Purdue University, where he earned the David and Lucille Packard Fellow award in 1989. He received a B.S. and an M.S. from the University of Windsor and a Ph.D. in Microbiology from the University of California, Davis.


James Severson

James A. Severson, Ph.D. - Director

Dr. Severson is a Principal with Pinnacle Reach LLC, a strategic consultancy for academic technology transfer offices.  Previously, he was the Vice Provost for Intellectual Property and Technology Transfer at the University of Washington. He led a turnaround of the technology transfer operations at the UW and under his leadership, all significant performance metrics showed marked improvements. In addition, Dr. Severson was the President of the Cornell Research Foundation where he was responsible for technology transfer from both Cornell’s Ithaca campus and the Weill Medical College of Cornell University in New York City, and he held technology transfer positions at the University of Minnesota.

Prior to this, Dr. Severson held positions in new technology assessment and pharmaceutical market development at Amersham Corporation.  He is a Past President of the Association of University Technology Managers (AUTM), a national organization of university technology transfer professionals, and has served as a member of the Board of Directors of the Council on Governmental Relations (COGR), a Washington-based association of over 140 research universities that focuses on the policies and issues of federally sponsored research programs at universities.  In 2005 Dr. Severson received the Bayh-Dole Award in recognition of his untiring efforts to foster and promote intellectual property activities on behalf of the university and nonprofit community. 

Dr. Severson received a B.S. in zoology and a Ph.D. in physiology from Iowa State University, and did postdoctoral research at the University of Southern California.  From 1980 to 1986 Dr. Severson held a faculty appointment in the University of Southern California School of Medicine.